Bionano Genomics, Inc. (BNGO)

Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies

Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms

Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript

Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026